QIAGEN Reports Fourth Quarter and Full-Year 2011 Results
January 31, 2012
VENLO, The Netherlands - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) has announced results of operations for the fourth quarter and full-year 2011, making significant progress on strategic initiatives to drive growth and innovation. Net sales in the fourth quarter advanced 17% (+17% at constant exchange rates, or CER) to $334.4 million from the [...]
Integrated DNA Technologies Introduces gBlocksTM Gene Fragments
January 31, 2012
CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, announced today that it is taking orders for a new product that represents a significant advancement for synthetic biology tools. gBlocks Gene Fragments are double-stranded, sequence-verified genomic blocks up to 500 base pairs. Their high sequence fidelity and rapid delivery time makes [...]
Definiens Strengthens Leadership with Key Appointment
January 31, 2012
Munich, Germany - Definiens, the global leader in Health Image Intelligence and Quantitative Digital Pathology, has appointed Martin Stuart, PhD, as its Executive Vice President and General Manager North America and Asian Pacific. In his new role, Stuart will be responsible for expanding the Definiens business in North America and Asia and providing leadership to [...]
Life Technologies Names Alan Sachs as Head of Global Research and Development
January 31, 2012
CARLSBAD, Calif.-- Life Technologies Corporation today announced that Alan B. Sachs, M.D., Ph.D., former Vice President, Exploratory and Translational Sciences for Merck Research Laboratories, has joined the company as Head of Global Research and Development. Sachs brings more than 20 years of experience as a research scientist and a leader in developing innovative scientific platforms. [...]
January 31, 2012
FRANKLIN LAKES, N.J. -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 45 cents per common share, payable on March 30, 2012 to holders of record on March 9, 2012. The indicated annual dividend rate is $1.80 per share. About BD BD is a leading [...]
Roche Diagnostics Announces Dan Zabrowski as New Head of Roche Applied Science
January 31, 2012
Penzberg, Germany - Dan Zabrowski is Head of Roche Applied Science in the Diagnostics Division, located in Penzberg, Germany. He succeeds Paul Brown who has led Roche Applied Science since September 2011. Dan Zabrowski will report to Daniel O’Day, COO Roche Diagnostics. Dan recently served as Global Head of Roche Partnering and was a member [...]
DNA2.0 Introduces Protein Variant Libraries
January 31, 2012
Menlo Park, California, DNA2.0 today introduced a complete line of Protein Variant Libraries designed to help researchers better engineer proteins. Four key library options —Alanine Scanning, Single Site Saturation, Combinatorial Site and Antibody—are suited for the most common methods of protein engineering, although DNA2.0 can produce additional libraries, such as Modular, Truncation or Random Mutagenesis [...]
Datacolor Unveils 45G Reference-grade Handheld Spectrophotometer
January 31, 2012
LAWRENCEVILLE, N.J.--Datacolor®, a global leader in color management solutions, announces the availability of the Datacolor 45G, a high accuracy handheld spectrophotometer with integrated gloss measurement. Datacolor 45G excels in color appearance evaluation of painted surfaces, plastic parts, package prints, automotive parts, commercial furniture and other manufactured goods. Measurements made with the 45G capture the effect [...]
Sapio Sciences Announces Exemplar Dx LIMS for Laboratories in the Burgeoning MDx Market
January 31, 2012
BALTIMORE-- Sapio Sciences is pleased to announce the immediate availability of Exemplar Dx LIMS. This release is the result of Sapio's extensive experience in implementing LIMS at leading MDx companies. Exemplar Dx LIMS addresses MDx companies' operational needs in a single, integrated solution. The MDx Market The molecular diagnostics market is experiencing rapid growth largely [...]
January 31, 2012
Roche announced today that it has provided notice to Illumina, Inc. (NASDAQ: ILMN) that it will nominate a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and propose certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which, if adopted, would result in Roche-nominated directors [...]
